55
DAFTAR PUSTAKA
1. 2.
3.
4. 5. 6.
7. 8.
9.
10. 11.
12.
13.
14.
American Cancer Society. Colorectal Cancer Facts and Figures 2014-2016. Am Cancer Soc. 2012:1-25. International Agency for Research on Cancer WHO. Fact Sheets by Population, Estimated Age-Standardise Incidence and Mortality Rates.; 2012. Diunduh dari: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Diakses terakhir: 17 November 2015. Riwanto I, Hamami AH, Pieter J, Tjambolang T, Ahmadsyah I. Usus Halus, Appendiks, Kolon, dan Anorektum. Dalam: Buku Ajar Ilmu Bedah. Edisi ketiga. Jakarta: EGC; 2012:731-98. Rizqhan M. Hubungan Indeks Eritrosit dan Kadar Haemoglobin terhadap Lokasi Tumor pada Pasien Kanker Kolorektal[Thesis]. Semarang: FKUNDIP; 2014. Tanaka T, Tanaka M, Tanaka T, Ishigamori R. Biomarkers for Colorectal Cancer. Int J Mol Sci. 2010:3209-25. Murray RK, Granner DK, Rodwell VW. Biokimia Harper. Edisi kedua puluh tujuh. Diterjemahkan oleh Brahm Udumbara dan Hartono Andry. (Maxine A. Papadakis M, Stephen J. McPhee M, Roni F. Zeiger M, eds.). Jakarta: EGC; 2006. Kumar V, Abbas AK, Fausto N. Dasar Patologis Penyakit; Robbins & Cotran. Edisi ketujuh. Diterjemahkan oleh Hartono Andry. Jakarta: EGC; 2010. Nazha B, Moussaly E, Zaarour M, Weerasinghe C, Azab B. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate. World J Gastrointest Surg. 2015;7(12):370-7. Nair R, Resident S, Nayal B, Rao BHA. Carcinoembryonic antigen, C-reactive protein, and albumin as prognostic indicators in colorectal carcinomas. Int J Sci Res. 2015;5(2):1-10. Sack J, Rothman JM. Colorectal Cancer : Natural History and Management. Pennsylvania: turner white communication; 2000. Yang K, Yang S, Liang W, Kuo Y, Lin J, et al. Carcinoembryonic antigen ( CEA ) level , CEA ratio , and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery. Radiat Oncol J. 2013:1-9. Mutmainah I. Perbedaan Kadar Carcinoembryonic Antigen (cea) Sebelum dan Sesudah Terapi pada Pasien dengan Karsinoma Kolorektal[Thesis]. Semarang: FKUNDIP;2006. Chang AC, Warren LR, Barreto SG, Williams R. Differing Serum Cea in Primary and Recurrent Rectal Cancer - A Reflection of Histology. world J Oncol. 2012;3(2):59-63. Demetri GD, Benjamin RS. NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines. J Natl Compr Cancer Netw. 2007;5:2-4.
56
15.
16. 17. 18. 19.
20.
21.
22. 23. 24. 25. 26. 27. 28. 29.
30.
31.
32.
American Cancer Society. Signs and symptoms of colorectal cancer. 2015. Diunduh dari: http://www.cancer.org/cancer/colonandrectumcancer/moreinformation/colonandr ectumcancerearlydetection/colorectal-cancer-early-detection-symptoms-of-crc. Diakses terakhir: 10 Desember 2015. IKABDI. Panduan Penatalaksanaan Kanker Kolorektal. Jakarta: IKABDI; 2014. Sadler TW. Embriologi Kedokteran Langman. Edisi kedua belas. Diterjemahkan oleh Joko Suyono. Jakarta: EGC; 2012. Yang JF, Tang S, Wu R, Yang Q. Distribution Patterns of Colorectal Cancer and its Precursors. North Am Med Sci. 2013;6(2):57-62. Palmieri G, Paliogiannis P, Scognamillo F, Budroni M, Cesaraccio R. Colorectal Cancer Epidemiology in an Area with a Spontaneous Screening. Acta Medica Mediterr. 2013:231-4. Ghanadi K, Anbari K, Obeidavi Z, Pournia Y. Characteristics of Colorectal Cancer in Khorramabad , Iran during 2013. Middle East J Dig Dis. 2014;6(2):816. Yadav RR, Saxena P, Bhatnagar PK, Saxena R, Navariya S, Porwal P. Colorectal Carcinoma in Western Rajasthan: A Comprehensive Study and Management of 245 Cases. J Evid Based Med Heal Care. 2014:1387-96. Fakih M, Padmanabhan A. CEA Monitoring in Colorectal Cancer. cancer Netw. 2006:1-12. Phatology Harmony. Tumour Marker Bookmark. 2012. Diunduh dari: http://pathologyharmony.co.uk/. Diakses terakhir pada 26 Desember 2015. Malati T. Tumour Markers : An Overview. Indian J Clin Biochem. 2007;22(2):17-31. Duffy MJ. Carcinoembryonic Antigen as a Marker for Colorectal Cancer: is it clinically useful?. Clin Chem. 2001;47(4):624-30. Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle. 2011;2:27-35. Merck & Co Inc. The Merck Manual of Diagnosis and Therapy. Edisi ke delapan belas. (Porter R, ed.). New Jersey: Whitehouse Station; 2007. Umar SB, DiBaise JK. Protein-Losing Enteropathy: Case Illustrations and Clinical Review. Am J Gastroenterol. 2010;105(1):43-9. Chen C-Y, Lee M-Y, Lin K-D, et al. Diabetes Mellitus Increases Severity of Thrombocytopenia in Dengue-Infected Patients. Int J Mol Sci. 2015;16(2):382030. Sah JP, Pandey R, Jaiswal S, Sharma B. Correlation of Hypoproteinemia and Hypoalbuminemia with Hypercholesterolemia in the Children with Nephrotic Syndrome. J Heal Prof. 2013;3(2):1-6. Lai C-C, You J-F, Yeh C-Y, Chen J-S, Tang R, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Color Dsease. 2011;4:473-81. Reunanen A, Stevens R, Knekt P, Hakulinen T, Leino A, Helio M. Serum albumin and colorectal cancer risk. Eur J Clin Nutr. 2000;54:460-2.
57
33.
34.
35.
36.
37.
38.
39. 40.
41.
42.
43.
44.
45.
Boonpipattanapong T, Chewatanakornkul S. Preoperative Carcinoembryonic Antigen and Albumin in Predicting Survival in Patients With Colon and Rectal Carcinomas. J Clin Gastroenterol. 2006;40(7):592-5. Rizaldi A. Pola Kadar CEA ( Carcinoembryonic Antigen ) Praoperatif pada Penderita Karsinoma Kolorektal ( KKR ) di Rumah Sakit Tempat Pendidikan FK USU MEDAN Tahun 2006-2008[Thesis]. Medan: FKUSU; 2008. Silalahi EM, Zain LH, Effendi R. Serum carcinoembryonic antigen tends to decrease in poorly-differentiated colorectal cancer. Universa Med. 2013;32(3):165-71. Ahmad B, Gul B, Ali S, Bashir S, Mahmood N, et al. Comparative Study of Carcinoembryonic Antigen Tumor Marker in Stomach and Colon Cancer Patients in Khyber Pakhtunkhwa. Asian Pacific J Cancer Prev. 2015;16:4497-502. Benny Y, Aryandono T. Hipoalbuminemia praoperasi pasien kanker kolorektal terhadap risiko komplikasi pascaoperasi dan lama rawat inap. J Gizi Klin Indones. 2013;9(4):170-8. Ba YP, Chang P, Fan C, Tseng W, Huang J, et al. Relationship between pretreatment nutritional status , serum glutamine , arginine levels and clinicopathological features in Taiwan colorectal cancer patients. Asian Pacific J Clin Nutr. 2015;24(4):598-604. Mik M, Dziki Ł, Trzciński R, Dziki A. Risk factors of 30-day mortality following surgery for colorectal cancer. De Gruyter Journals. 2016;88(1):26-31. Tatuhey WS, Nikijuluw H, Mainase J. Karakteristik Kanker Kolorektal di RSUD Dr. M Haulussy Ambon Periode Januari 2012–Juni 2013. Molucca Medica. 2014;4(2):150-7. Dbouk HA, Tawil A, Nasr F, Kandakarjian L, Abou-merhi R. Significance of CEA and VEGF as Diagnostic Markers of Colorectal Cancer in Lebanese Patients. Open Clin Cancer J. 2007:1-5. Filiz AI, Sucullu I, Kurt Y, Karakas DO. Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients- is it important. Clinics. 2009;64(4):287-94. Su B, Shi H, Wan J. Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection. World J Gastroenterol. 2012;18(17):2121-6. Pastore CA, Orlandi SP, González MC. Association between an inflammatorynutritional index and nutritional status in cancer patients. Nutr Hosp. 2013;28(1):188-93. Abdullah M, Sudoyo AW, Utomo AR, Fauzi A, Rani AA. Molecular profile of colorectal cancer in Indonesia : is there another pathway. Res Inst Gastroenterol Liver Dis. 2012;5(2):71-8.
58
Lampiran 1. Ethical Clearance
59
Lampiran 2. Izin penelitian
60
Lampiran 3. Spreadsheet data Kadar
Kadar
CEA(ng/mL)
Albumin(g/dL)
52
3,71
3,4
rektum
C511180
44
6,3
4,2
rektum
3 PRIA
C462051
52
1,68
2,7
rektum
4 PRIA
C435820
86
6,57
3,3
rektum
5 PRIA
C550170
56
>200
3
rektum
6 PRIA
C516776
40
20,25
2,1
kolon kanan
7 WANITA
C485919
51
0,5
3,1
rektum
8 PRIA
C481116
59
19,01
2
kolon kiri
9 PRIA
C482329
44
45
3,4
kolon kanan
10 PRIA
C478209
43
0,56
2,7
kolon kiri
11 WANITA
C466768
44
2,94
2,3
rektum
12 WANITA
C466417
55
3,75
3,3
rektum
13 PRIA
C522771
33
86,42
3,2
rektum
14 PRIA
C543453
53
4,89
3,4
kolon kanan
15 PRIA
C372955
68
3,93
4,5
kolon kiri
16 WANITA
C404188
49
7,58
3,8
rektum
17 PRIA
C449561
45
3,34
3,8
rektum
18 WANITA
C454727
64
>200
3,2
rektum
19 WANITA
C551782
25
2,17
3,4
rektum
20 WANITA
C564002
42
4,69
3,5
rektum
21 PRIA
C502982
50
>200
2,3
rektum
22 WANITA
C511221
55
0,51
3,5
rektum
23 PRIA
C490970
60
34,07
3,6
rektum
24 WANITA
C348210
50
4,04
2,6
rektum
25 PRIA
C550155
46
>200
3,4
kolon kiri
26 PRIA
C549684
72
2,19
3,5
rektum
27 PRIA
C482663
25
13,98
3,3
rektum
No
Jenis
No CM
Usia
1 WANITA
C450652
2 WANITA
Kelamin
Lokasi Tumor
61
28 WANITA
C504773
65
1,52
3,5
rektum
29 PRIA
C547366
45
91,65
3,7
rektum
30 WANITA
C532129
67
2,01
2,1
kolon kanan
31 WANITA
C506009
49
32,44
3,3
rektum
32 PRIA
C312982
35
1,84
3
rektum
33 PRIA
C346393
47
184,16
2,9
rektum
34 WANITA
C055350
80
19,36
3,8
rektum
35 PRIA
C330851
52
2,23
4,2
rektum
36 PRIA
C269460
59
0,93
3,7
kolon kiri
37 WANITA
B047331
64
34,27
3,6
rektum
38 WANITA
C357031
22
19,40
3,3
rektum
39 PRIA
C414908
51
6,78
3,9
rektum
40 PRIA
C304668
36
93,20
2
kolon kanan
41 WANITA
C176538
66
2,56
3,4
rektum
42 WANITA
C294646
81
43,25
1,6
rektum
43 PRIA
C346208
58
2,71
3,5
rektum
44 WANITA
C358798
32
>200
1,9
rektum
45 PRIA
C326770
36
3,01
3
rektum
46 WANITA
C388774
49
5,17
2,3
rektum
47 WANITA
C448519
58
31,27
4,4
rektum
48 PRIA
C381149
49
2,09
4,1
rektum
49 PRIA
C378817
38
1,41
3,9
rektum
50 PRIA
C389019
46
>200
4,1
rektum
51 WANITA
C395146
64
177,92
3,4
rektum
52 WANITA
C395644
47
6,27
3,2
kolon kiri
53 WANITA
C430930
34
0,56
4,2
kolon kiri
54 WANITA
C470382
59
0,96
3
rektum
55 PRIA
C449523
53
2,46
2,7
rektum
56 WANITA
C401744
51
>200
1,5
rektum
57 WANITA
C400420
25
>200
4,8
rektum
58 PRIA
C401271
44
1,18
2,8
rektum
62
59 WANITA
C399940
54
11,81
1,7
rektum
60 PRIA
C401056
59
13,21
1,8
rektum
61 WANITA
C404487
34
>200
3,1
kolon kiri
62 WANITA
C407729
38
15,15
2,2
kolon kiri
63 WANITA
C401568
72
88,89
3,9
rektum
63
Lampiran 4. Output analisis program statistik
ceanominal * LOKASI Crosstabulation LOKASI kolonkanan Count
Total
kolonkiri
rektum
2
4
22
28
40,0%
44,4%
44,9%
44,4%
3
5
27
35
60,0%
55,6%
55,1%
55,6%
5
9
49
63
100,0%
100,0%
100,0%
100,0%
LOKASI
ceanominal
<=5 % within LOKASI ceanominal Count >5 % within LOKASI Count Total % within LOKASI
Correlations LOKASI-ceanominal
Correlation Coefficient LOKASI
1,000
-,019
.
,880
63
63
-,019
1,000
,880
.
63
63
Sig. (2-tailed) N
Spearman's rho Correlation Coefficient ceanominal
Sig. (2-tailed) N
albuminnominal * LOKASI Crosstabulation LOKASI kolonkanan Count
Total
kolonkiri
rektum
0
0
1
1
0,0%
0,0%
2,0%
1,6%
2
4
23
29
40,0%
44,4%
46,9%
46,0%
3
5
25
33
60,0%
55,6%
51,0%
52,4%
5
9
49
63
100,0%
100,0%
100,0%
100,0%
>4,7 % within LOKASI Count albuminnominal
3,4-<=4,7 % within LOKASI Count <3,4 % within LOKASI Count
Total % within LOKASI
64
Correlations LOKASI- albuminnominal LOKASI
albuminnomin al
Correlation
1,000
-,060
.
,642
63
63
-,060
1,000
,642
.
63
63
Coefficient LOKASI
Sig. (2-tailed) N
Spearman's rho Correlation Coefficient albuminnominal
Sig. (2-tailed) N
Correlations LOKASI- kombinasi LOKASI Correlation Coefficient LOKASI
Sig. (2-tailed) N
kombinasi
1,000
-,048
.
,709
63
63
-,048
1,000
,709
.
63
63
Spearman's rho Correlation Coefficient kombinasi2
Sig. (2-tailed) N
65
Lampiran 5. Biodata penulis Identitas Nama
: Fathoni Ridwan Permana
NIM
: 22010112130101
Tempat/tanggal lahir : Surakarta, 16 Desember 1992 Jenis kelamin
: Laki-laki
Alamat
: Jalan Muwardi Raya No. 29, Pedurungan, Semarang 50198
Nomor Telpon
:-
Nomor HP
: 082227832145
e-mail
:
[email protected]
Riwayat Pendidikan Formal 1. SD
: SD Sriwulan 1 Demak
Lulus tahun: 2005
2. SMP
: SMP Negeri 2 Semarang
Lulus tahun: 2008
3. SMA
: SMA Negeri 3 Semarang
Lulus tahun: 2011
4. FK UNDIP : Masuk tahun: 2012 Keanggotaan Organisasi 1. Staf RISET HIMA KU 2. Ketua RISET HIMA KU
Tahun 2013 s/d 2014 Tahun 2014 s/d 2015
